Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.12 PLN | 0.00% | +3.87% | +4.27% |
Business Summary
Number of employees: 513
Sales per Business
PLN in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Generic Drugs
83.6
%
| 173 | 86.7 % | 163 | 83.6 % | -5.77% |
Innovative
16.4
%
| 27 | 13.3 % | 32 | 16.4 % | +20.52% |
Sales per region
PLN in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Poland
100.0
%
| 199 | 100.0 % | 195 | 100.0 % | -2.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Maciej Wieczorek
CEO | Chief Executive Officer | - | 20/02/20 |
Investor Relations Contact | - | 01/17/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Rzeminski
CHM | Chairman | - | - |
Director/Board Member | - | - | |
Director/Board Member | 62 | 16/21/16 | |
Director/Board Member | - | 01/05/01 | |
Artur Wieczorek
BRD | Director/Board Member | - | 01/13/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,056,500 | 21,028,969 ( 41.19 %) | 0 | 41.19 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.27% | 206M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- CLN Stock
- Company Celon Pharma S.A.